Quviviq (daridorexant) / Shionogi, Simcere, Nxera Pharma, Mochida, Syneos Health, Idorsia  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quviviq (daridorexant) / Idorsia, Syneos Health, Nxera Pharma, Simcere
NCT02839200 / 2016-000826-21: Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Completed
2
360
Europe, US, RoW
ACT-541468 5 mg, ACT-541468 10 mg, ACT-541468 25 mg, Zolpidem, Placebo 1, Placebo 2
Idorsia Pharmaceuticals Ltd.
Insomnia Disorder
04/17
06/17
NCT02841709 / 2016-000827-16: Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

Completed
2
58
Europe, US
ACT-541468, Placebo
Idorsia Pharmaceuticals Ltd.
Insomnia Disorder
05/17
06/17
NCT05423717 / 2021-003867-87: Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Recruiting
2
150
Europe, US
Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg, Placebo
Idorsia Pharmaceuticals Ltd., Idorsia Pharmaceuticals Ltd
Insomnia
03/25
04/25
NCT05948540: Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Recruiting
2
200
US
Intervention C Daridorexant, Intervention C Placebo
U.S. Army Medical Research and Development Command, PPD, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Recruiting
2
600
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo
U.S. Army Medical Research and Development Command, PPD, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26

Download Options